Mukanov K, Mukantayev K, Tarlykov P. GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER. Eurasian Journal of Applied Biotechnology [Internet]. 2018Jan.10 [cited 2024Nov.21];(1). Available from: https://biotechlink.org/index.php/journal/article/view/76